These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8474936)

  • 1. Pharmacokinetic considerations in quinolone therapy.
    Nightingale CH
    Pharmacotherapy; 1993; 13(2 Pt 2):34S-38S. PubMed ID: 8474936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics and tissue penetration of the fluoroquinolones.
    Bergeron MG
    Clin Invest Med; 1989 Feb; 12(1):20-7. PubMed ID: 2920479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quinolones: a practical review of clinical uses, dosing considerations, and drug interactions.
    Borcherding SM; Stevens R; Nicholas RA; Corley CR; Self T
    J Fam Pract; 1996 Jan; 42(1):69-78. PubMed ID: 8537808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-drug interactions with fluoroquinolones.
    Marchbanks CR
    Pharmacotherapy; 1993; 13(2 Pt 2):23S-28S. PubMed ID: 8474934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.
    Okuyama Y; Momota K; Morino A
    Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic development of quinolone antibiotics.
    Schaefer HG; Ahr G; Kuhlmann J
    Int J Clin Pharmacol Ther; 1995 May; 33(5):266-76. PubMed ID: 7655765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Maalox on the oral absorption of sparfloxacin.
    Johnson RD; Dorr MB; Talbot GH; Caille G
    Clin Ther; 1998; 20(6):1149-58. PubMed ID: 9916608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug interactions with quinolones.
    Lode H
    Rev Infect Dis; 1988; 10 Suppl 1():S132-6. PubMed ID: 3279488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoroquinolones: interaction profile during enteral absorption.
    Deppermann KM; Lode H
    Drugs; 1993; 45 Suppl 3():65-72. PubMed ID: 7689454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of the newer fluoroquinolones.
    Brouwers JR
    Pharm Weekbl Sci; 1987 Dec; 9 Suppl():S16-22. PubMed ID: 3325926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue distribution and disposition kinetics of enrofloxacin in healthy and E. coli infected broilers.
    Soliman GA
    Dtsch Tierarztl Wochenschr; 2000 Jan; 107(1):23-7. PubMed ID: 10689795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic studies in rats with ofloxacin and MF-934, a new fluorinated quinolone.
    Mattina R; Bellotti M; Raimondi A; Sander K
    Chemioterapia; 1987 Jun; 6(2 Suppl):302-3. PubMed ID: 3334569
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetics of enrofloxacin in adult horses and concentration of the drug in serum, body fluids, and endometrial tissues after repeated intragastrically administered doses.
    Giguère S; Sweeney RW; Bélanger M
    Am J Vet Res; 1996 Jul; 57(7):1025-30. PubMed ID: 8807015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of an aluminum- and magnesium-containing antacid on the bioavailability of garenoxacin in healthy volunteers.
    Krishna G; Kisicki JC; Olsen S; Grasela DM; Wang Z
    Pharmacotherapy; 2007 Jul; 27(7):963-9. PubMed ID: 17594201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug interactions with quinolones.
    Janknegt R
    J Antimicrob Chemother; 1990 Nov; 26 Suppl D():7-29. PubMed ID: 2286594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concentrations of the des-F(6)-quinolone garenoxacin in plasma and joint cartilage of immature rats.
    Kastner M; Rahm U; Baumann-Wilschke I; Bello A; Stahlmann R
    Arch Toxicol; 2004 Feb; 78(2):61-7. PubMed ID: 14661070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse reactions and interactions of fluoroquinolones.
    Ball P
    Clin Invest Med; 1989 Feb; 12(1):28-34. PubMed ID: 2646053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new respiratory fluoroquinolone, oral gemifloxacin: a safety profile in context.
    Ball P; Mandell L; Patou G; Dankner W; Tillotson G
    Int J Antimicrob Agents; 2004 May; 23(5):421-9. PubMed ID: 15120718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum concentrations and pharmacokinetics of enrofloxacin after intravenous and intragastric administration to mares.
    Haines GR; Brown MP; Gronwall RR; Merritt KA
    Can J Vet Res; 2000 Jul; 64(3):171-7. PubMed ID: 10935883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical evaluation of new quinolones as antituberculosis drugs].
    Kawahara S; Tada A; Nagare H
    Kekkaku; 1999 Jan; 74(1):71-5. PubMed ID: 10067058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.